chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Sex: M
Vaccine: PPV
Symptoms: Injection site cellulitis
Clinical narrative: This spontaneous report as received from a physician via a field representative refers to a male patient of unknown age. On an unknown date in March 2014, the patient was vaccinated with a dose of PNEUMOVAX 23 (dose, route and lot# unknown). On an unknown date the patient developed cellulitis in a large area around the site of injection. The patient visited an unspecified urgent care facility on an unspecified date and received treatment as follows: patient was prescribed prednisone (manufacturer unknown), vancomycin and ceftriaxone. Patient was not admitted to a hospital. Patient was fully recovered on an unspecified date. The causality was not reported. Additional information has been requested.
Sex: U
Vaccine: HEP
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from an office manager refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients had been administered RECOMBIVAX HB (dose, frequency, route, lot # and expired date were not reported) that fell to refrigerator temperatures outside the prescribing information, despite being supported. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Age: 4.0
Sex: M
Vaccine: MMRV, UNK
Symptoms: Injection site erythema, Injection site pain, Injection site swelling
Clinical narrative: This spontaneous report as received from a medical assistant refers to a 4 year old male patient. On 02-JUN-2014, the patient was vaccinated with PROQUAD (dose and lot # not reported) subcutaneously. Concomitant therapy included an unspecified vaccine that was given in the opposite leg. The medical assistant reported that on 03-JUN-2014, the patient developed a significant pain swelling and redness at the injection site and upper thigh after receipt of PROQUAD. At the time of the report, the patient had not recovered. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from an office manager refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients had been administered GARDASIL (dose, frequency, route, lot # and expired date were not reported) that fell to refrigerator temperatures outside the prescribing information, despite being supported. No adverse effects reported. This is one of several received from the same source. Additional information has been requested.
Sex: U
Vaccine: HEPA
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from an office manager refers to an unspecified number of patients of unknown age and gender. On an unknown date, the patients had been VAQTA (dose, frequency, route, lot # and expired date were not reported) that fell to refrigerator outside the prescribing information, despite being supported. No adverse effects reported. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with VARIVAX (lot# and expiration date not provided) (dose not reported). On an unknown date the patient received dose of VARIVAX that was exposed to temperature above the recommended temperature range. No adverse effect was reported. This is one of several reports from the same reporter (Same Reporter Link: MARRS#1405USA014687, MARRS#1405USA015420, MARRS#1405USA015421, MARRS#1405USA015423). Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Drug administered at inappropriate site, No adverse event
Clinical narrative: This spontaneous report as received from a nurse practitioner refers to a patient of unknown age and gender. No information provided regarding medical history, concurrent conditions and drug reactions/allergies reported. On an unknown date of MAY-2014, reported as early May, the patient was vaccinated with ZOSTAVAX (dose, route, lot# not provided). No concomitant medications reported. On an unknown date of MAY-2014 the patient received a dose of ZOSTAVAX at a local pharmacy clinic and patient reported that ZOSTAVAX was administered in patient's stomach area. No adverse effects reported. PQC not involved. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a patient of unknown age and gender. Medical history and concurrent conditions were not reported. On 23-MAY-2014, the patient was vaccinated with GARDASIL lot # J012212, expiration date 18-FEB-2016, 0.5 ml, intramuscular. No co-suspect and concomitant therapies were reported. The nurse reported that an improperly GARDASIL stored was administered. She stated that the GARDASIL was exposed to a temperature of 69F for 21 days (504 hours). she reported that the GARDASIL was administered to the patient on "day 14 of the 21 day excursion". No adverse effect reported. Additional information has been requested.
Sex: M
Vaccine: VARCEL
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a patient of unknown age and gender. On an unknown date the patient was vaccinated with VARIVAX (lot# and expiration date not provided) (dose not reported). On an unknown date the patient received dose of VARIVAX that was exposed to temperature above the recommended temperature range. No adverse effect was reported. This is one of several reports from the same reporter (Same Reporter Link: MARRS#1405USA014687, MARRS#1405USA015420, MARRS#1405USA015421, MARRS#1405USA015422). Additional information has been requested.
Age: 76.0
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Injection site erythema, Injection site warmth, Local swelling
Clinical narrative: ZOSTAVAX administered on 5-21-14. On 6-5-14 the patient notified pharmacy of reaction - injection site was red and hot for first 2 day. It became swollen from elbow to fingers. We called prescriber on 6-6-14. We advised patient to see doctor. I called patient to follow up on 6-9-14. He took prednisone and was doing fine - reaction gone.
Age: 76.0
Sex: M
Vaccine: VARZOS, VARZOS, VARZOS
Symptoms: Arthralgia, Injection site swelling, Local swelling
Clinical narrative: ZOSTAVAX administered on 5-21-14. On 6-5-14 the patient notified pharmacy of reaction - injection site was red and hot for first 2 day. It became swollen from elbow to fingers. We called prescriber on 6-6-14. We advised patient to see doctor. I called patient to follow up on 6-9-14. He took prednisone and was doing fine - reaction gone.
Age: 0.35
Sex: M
Vaccine: DTAPIPVHIB, PNC13, RV5
Symptoms: Rash papular, Urticaria
Clinical narrative: Rash that started papular then proceeded to hives over few hours.
Age: 17.0
Sex: F
Vaccine: MNQ, TDAP
Symptoms: Rash, Tenderness
Clinical narrative: Pts father called to report patient having "rash" on trunk, back and some on hands. Bumps described as tender. Attempted x3 to speak with patient directly but no answer to her phone #.
Age: 2.0
Sex: F
Vaccine: TYP, TYP
Symptoms: Decreased appetite, Erythema, Papule, Pyrexia, Rash pruritic
Clinical narrative: On the late afternoon/evening of 6/08, father of this 2 yo female patient noticed a rash on her abdomen, chest and back, and small amount on arms. Rash was mildly pruritic. Patient had decreased appetite and vomited once. Father reports she may have had a low-grade temperature yesterday (not measured). No changes in stool. Father noted patient was not as playful and energetic as usual. He treated rash with diphenhydramine 2% topical cream which gave patient some relief. Appetite somewhat improved today. No further N/V. Rash has started to diminish. No swelling or difficulty breathing. Father is unaware of any recent exposure to new animals/household chemicals/fragrances/soaps or other new potential allergens. On Exam this morning (6/09), patient appears happy, playful, communicative, without itching. Skin: mild generalized rash on abdomen/chest and back - colorless slightly raised papules s/o erythema, barely visible. Face and extremities clear. Oral cavity/lips clear. No urticaria/hives. Lungs: CTA Heart: RRR Temp: NL.
Age: 2.0
Sex: F
Vaccine: TYP, TYP
Symptoms: Vomiting
Clinical narrative: On the late afternoon/evening of 6/08, father of this 2 yo female patient noticed a rash on her abdomen, chest and back, and small amount on arms. Rash was mildly pruritic. Patient had decreased appetite and vomited once. Father reports she may have had a low-grade temperature yesterday (not measured). No changes in stool. Father noted patient was not as playful and energetic as usual. He treated rash with diphenhydramine 2% topical cream which gave patient some relief. Appetite somewhat improved today. No further N/V. Rash has started to diminish. No swelling or difficulty breathing. Father is unaware of any recent exposure to new animals/household chemicals/fragrances/soaps or other new potential allergens. On Exam this morning (6/09), patient appears happy, playful, communicative, without itching. Skin: mild generalized rash on abdomen/chest and back - colorless slightly raised papules s/o erythema, barely visible. Face and extremities clear. Oral cavity/lips clear. No urticaria/hives. Lungs: CTA Heart: RRR Temp: NL.
Age: 2.0
Sex: F
Vaccine: TYP, TYP
Symptoms: Body temperature decreased, Decreased appetite, Energy increased, Rash, Rash papular
Clinical narrative: On the late afternoon/evening of 6/08, father of this 2 yo female patient noticed a rash on her abdomen, chest and back, and small amount on arms. Rash was mildly pruritic. Patient had decreased appetite and vomited once. Father reports she may have had a low-grade temperature yesterday (not measured). No changes in stool. Father noted patient was not as playful and energetic as usual. He treated rash with diphenhydramine 2% topical cream which gave patient some relief. Appetite somewhat improved today. No further N/V. Rash has started to diminish. No swelling or difficulty breathing. Father is unaware of any recent exposure to new animals/household chemicals/fragrances/soaps or other new potential allergens. On Exam this morning (6/09), patient appears happy, playful, communicative, without itching. Skin: mild generalized rash on abdomen/chest and back - colorless slightly raised papules s/o erythema, barely visible. Face and extremities clear. Oral cavity/lips clear. No urticaria/hives. Lungs: CTA Heart: RRR Temp: NL.
Age: 2.0
Sex: F
Vaccine: TYP, TYP
Symptoms: Rash pruritic, Vomiting
Clinical narrative: On the late afternoon/evening of 6/08, father of this 2 yo female patient noticed a rash on her abdomen, chest and back, and small amount on arms. Rash was mildly pruritic. Patient had decreased appetite and vomited once. Father reports she may have had a low-grade temperature yesterday (not measured). No changes in stool. Father noted patient was not as playful and energetic as usual. He treated rash with diphenhydramine 2% topical cream which gave patient some relief. Appetite somewhat improved today. No further N/V. Rash has started to diminish. No swelling or difficulty breathing. Father is unaware of any recent exposure to new animals/household chemicals/fragrances/soaps or other new potential allergens. On Exam this morning (6/09), patient appears happy, playful, communicative, without itching. Skin: mild generalized rash on abdomen/chest and back - colorless slightly raised papules s/o erythema, barely visible. Face and extremities clear. Oral cavity/lips clear. No urticaria/hives. Lungs: CTA Heart: RRR Temp: NL.
Age: 60.0
Sex: F
Vaccine: VARZOS
Symptoms: Erythema, Skin warm
Clinical narrative: Redness to surrounding tissue, warm to touch. Tx: PO ZYRTEC, Ice pack.
Age: 67.0
Sex: M
Vaccine: VARZOS
Symptoms: Pruritus, Rash generalised
Clinical narrative: Rash all over body and itching.
Age: 58.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site pruritus, Injection site warmth
Clinical narrative: Patient had itching, warmth and redness at injection site.
Age: 68.0
Sex: M
Vaccine: VARZOS
Symptoms: Erythema, Hypersensitivity, Local swelling, Pruritus, Skin warm
Clinical narrative: The patient mentioned he experienced local redness, warmth, itching. Swelling tenderness on left arm. It got worse so he was treated by dr at the urgent care clinic. We've added this new allergy info in patient's allergy profile.
Age: 68.0
Sex: M
Vaccine: VARZOS
Symptoms: Tenderness
Clinical narrative: The patient mentioned he experienced local redness, warmth, itching. Swelling tenderness on left arm. It got worse so he was treated by dr at the urgent care clinic. We've added this new allergy info in patient's allergy profile.
Age: 69.0
Sex: M
Vaccine: VARZOS
Symptoms: Adverse reaction, Lethargy, Nausea
Clinical narrative: Patient received Zoster vaccine at clinic 9/4/12. Provider learned months later that patient had subsequently c/o adverse reaction to the health department. Patient reportedly experienced lethargy and nauseas within a few hours after receiving the dose, lasting 4-6 hours. Patient did not report this reaction to his provider at the time, but patient later confirmed the report upon further inquiry.
Age: 3.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Anaemia, Leukaemia, Pyrexia
Clinical narrative: Seen for well child care visit 5/6/14 and received MMR #1. Hx of decreased energy, low grade fever on 5/11/ and 5/12 < 100 degrees F. Fever 102.9 on 5/15 and 5/16, broke on 5/17, C/O leg pain, walking on tip toes, decreased appetite, pale. Labs done - Hgb 4.2. CBC W/Diff White blood count 5.7 Red blood count 1.53 Hemoglobim 4.6. Hematocrit 13.1 Mean cell volume 85 Mean corpuscular Hgb 29.9 Mean corpuscular Hgb Conc 35.2 Platelet count 105 Gran % 3.2 Baso % 0.2 Lymph % 94.1 Mono % 2.4 Eos % 0.1 ABS Neutrophils 0.2. Ferritin 518.
Age: 3.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Acute lymphocytic leukaemia, Asthenia, Basophil percentage decreased, Decreased appetite, Differential white blood cell count
Clinical narrative: Seen for well child care visit 5/6/14 and received MMR #1. Hx of decreased energy, low grade fever on 5/11/ and 5/12 < 100 degrees F. Fever 102.9 on 5/15 and 5/16, broke on 5/17, C/O leg pain, walking on tip toes, decreased appetite, pale. Labs done - Hgb 4.2. CBC W/Diff White blood count 5.7 Red blood count 1.53 Hemoglobim 4.6. Hematocrit 13.1 Mean cell volume 85 Mean corpuscular Hgb 29.9 Mean corpuscular Hgb Conc 35.2 Platelet count 105 Gran % 3.2 Baso % 0.2 Lymph % 94.1 Mono % 2.4 Eos % 0.1 ABS Neutrophils 0.2. Ferritin 518.
Age: 3.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Eosinophil percentage decreased, Full blood count, Granulocyte percentage, Haematocrit decreased, Haemoglobin decreased
Clinical narrative: Seen for well child care visit 5/6/14 and received MMR #1. Hx of decreased energy, low grade fever on 5/11/ and 5/12 < 100 degrees F. Fever 102.9 on 5/15 and 5/16, broke on 5/17, C/O leg pain, walking on tip toes, decreased appetite, pale. Labs done - Hgb 4.2. CBC W/Diff White blood count 5.7 Red blood count 1.53 Hemoglobim 4.6. Hematocrit 13.1 Mean cell volume 85 Mean corpuscular Hgb 29.9 Mean corpuscular Hgb Conc 35.2 Platelet count 105 Gran % 3.2 Baso % 0.2 Lymph % 94.1 Mono % 2.4 Eos % 0.1 ABS Neutrophils 0.2. Ferritin 518.
Age: 3.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Lymphocyte percentage increased, Mean cell haemoglobin concentration normal, Mean cell haemoglobin normal, Mean cell volume normal, Monocyte percentage
Clinical narrative: Seen for well child care visit 5/6/14 and received MMR #1. Hx of decreased energy, low grade fever on 5/11/ and 5/12 < 100 degrees F. Fever 102.9 on 5/15 and 5/16, broke on 5/17, C/O leg pain, walking on tip toes, decreased appetite, pale. Labs done - Hgb 4.2. CBC W/Diff White blood count 5.7 Red blood count 1.53 Hemoglobim 4.6. Hematocrit 13.1 Mean cell volume 85 Mean corpuscular Hgb 29.9 Mean corpuscular Hgb Conc 35.2 Platelet count 105 Gran % 3.2 Baso % 0.2 Lymph % 94.1 Mono % 2.4 Eos % 0.1 ABS Neutrophils 0.2. Ferritin 518.
Age: 3.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Neutrophil count decreased, Pain, Pain in extremity, Pallor, Platelet count decreased
Clinical narrative: Seen for well child care visit 5/6/14 and received MMR #1. Hx of decreased energy, low grade fever on 5/11/ and 5/12 < 100 degrees F. Fever 102.9 on 5/15 and 5/16, broke on 5/17, C/O leg pain, walking on tip toes, decreased appetite, pale. Labs done - Hgb 4.2. CBC W/Diff White blood count 5.7 Red blood count 1.53 Hemoglobim 4.6. Hematocrit 13.1 Mean cell volume 85 Mean corpuscular Hgb 29.9 Mean corpuscular Hgb Conc 35.2 Platelet count 105 Gran % 3.2 Baso % 0.2 Lymph % 94.1 Mono % 2.4 Eos % 0.1 ABS Neutrophils 0.2. Ferritin 518.
Age: 3.0
Sex: M
Vaccine: MMR, MMR
Symptoms: Pyrexia, Red blood cell count decreased, Serum ferritin increased, Toe walking, White blood cell count normal
Clinical narrative: Seen for well child care visit 5/6/14 and received MMR #1. Hx of decreased energy, low grade fever on 5/11/ and 5/12 < 100 degrees F. Fever 102.9 on 5/15 and 5/16, broke on 5/17, C/O leg pain, walking on tip toes, decreased appetite, pale. Labs done - Hgb 4.2. CBC W/Diff White blood count 5.7 Red blood count 1.53 Hemoglobim 4.6. Hematocrit 13.1 Mean cell volume 85 Mean corpuscular Hgb 29.9 Mean corpuscular Hgb Conc 35.2 Platelet count 105 Gran % 3.2 Baso % 0.2 Lymph % 94.1 Mono % 2.4 Eos % 0.1 ABS Neutrophils 0.2. Ferritin 518.
Age: 1.65
Sex: M
Vaccine: MMRV
Symptoms: Diarrhoea, Pyrexia
Clinical narrative: Fever, diarrhea.
Age: 12.0
Sex: M
Vaccine: MNQ
Symptoms: Cellulitis, Erythema, Skin warm, Swelling
Clinical narrative: The day after the vaccine was administered. There was a cellulitis reaction. From the shoulder to the elbow, radiating to the chest. Red, swollen and hot.
Age: 1.52
Sex: F
Vaccine: DTAP
Symptoms: Chills, Convulsion, Electroencephalogram, Musculoskeletal stiffness, Postictal state
Clinical narrative: Baby had a seizure: staring, teeth chattering, stiffened body, post dictal state afterwards.
Age: 1.52
Sex: F
Vaccine: DTAP
Symptoms: Staring
Clinical narrative: Baby had a seizure: staring, teeth chattering, stiffened body, post dictal state afterwards.
Age: 70.0
Sex: M
Vaccine: PPV
Symptoms: Chills, Discomfort, Headache, Injection site erythema, Injection site pain
Clinical narrative: Head Ache, fever and chills. Injection site red and extremely sore. Very uncomfortable. Unable to sleep.
Age: 70.0
Sex: M
Vaccine: PPV
Symptoms: Insomnia, Pyrexia
Clinical narrative: Head Ache, fever and chills. Injection site red and extremely sore. Very uncomfortable. Unable to sleep.
Age: 30.0
Sex: F
Vaccine: TDAP
Symptoms: Erythema, Infection, Skin warm, Swelling
Clinical narrative: Upon waking up a red dot the size of a dime appeared. Was hot and there was round raised bump underneath. By 3pm the size had spread to about 1 inch in diameter with increased temperature. On 6/6 it had expanded 1/2 inch upon waking. By 3pm it had expanded another 1/4". Going in for a follow up my doctor looked at the arm and indicated that it was infected and prescribed antibiotics.
Sex: U
Vaccine: PPV
Symptoms: Autopsy, Death, Ill-defined disorder
Clinical narrative: Information has been reported in a study. The report includes VAERS reports following PNEUMOVAX 23 or Pneumococcal polysaccharide vaccine (PPSV23) brand unknown after 2002. The report includes reports information from 01-JAN-1990 to 31-JAN-2014. This spontaneous report as received from a other health professional refers to 4 patients. The median age of the patients was 69 years old; range being 23 to 98 years. Between 01-JAN-1990 and 31-DEC-2013 patients were vaccinated with PNEUMOVAX 23. On an unknown date the patients experienced death. The outcome of death was reported as fatal. The cause of death was reported as 'other non infectious'. The death of the patients was confirmed with medical records, autopsy reports and/or death certificates. The report has been split into cases according to cause of death. This case is linked to same reporter linked cases 1406USA003857 (respiratory disorder), 1406USA003863 (Unknown), 1406USA003858 (other infectious disorder), 1406USA003860 (gastrointestinal), 1406USA003861 (Neurological), 1406USA003862 (Undetermined) and 1406USA003351 (Cardiovascular). Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Autopsy, Cardiovascular disorder, Death
Clinical narrative: Information has been reported in a study. The report includes VAERS reports following PNEUMOVAX 23 or Pneumococcal polysaccharide vaccine (PPSV23) brand unknown after 2002. The report includes reports information from 01-JAN-1990 to 31-JAN-2014. This spontaneous report as received from an other health professional refers to 16 patients. The median age of the patients was 69 years old; range being 23 to 98 years. Between 01-JAN-1990 and 31-DEC-2013 patients were vaccinated with PNEUMOVAX 23. On an unknown date the patients experienced death. The outcome of death was reported as fatal. The cause of death was reported as Cardiovascular. The death of the patients was confirmed with medical records, autopsy reports and/or death certificates. The report has been split into cases according to cause of death. This case is linked to same reporter linked cases 1406USA003857 (respiratory disorder), 1406USA003858 (Other infectious disorder), 1406USA003859 (other non infectious disorder), 1406USA003860 (gastrointestinal), 1406USA003861 (Neurological), 1406USA003862 (Undetermined) and 1406USA003863 (Unknown). Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Autopsy, Death, Nervous system disorder
Clinical narrative: Information has been reported in a study. The report includes VAERS reports following PNEUMOVAX 23 or Pneumococcal polysaccharide vaccine (PPSV23) brand unknown after 2002. The report includes reports information from 01-JAN-1990 to 31-JAN-2014. This spontaneous report as received from a other health professional refers to 2 patients. The median age of the patients was 69 years old; range being 23 to 98 years. Between 01-JAN-1990 and 31-DEC-2013 patients were vaccinated with PNEUMOVAX 23. On an unknown date the patients experienced death. The outcome of death was reported as fatal. The cause of death was reported as neurological. The death of the patients was confirmed with medical records, autopsy reports and/or death certificates. The report has been split into cases according to cause of death. This case is linked to same reporter linked cases 1406USA003857 (respiratory disorder), 1406USA003863 (Unknown), 1406USA003859 (other non infectious disorder), # 1406USA003860 (gastrointestinal), 1406USA003858 (other infectious), # 1406USA003862 (Undetermined) and 1406USA003351 (Cardiovascular). Additional information has been requested.
Sex: U
Vaccine: PPV
Symptoms: Autopsy, Death, Infection
Clinical narrative: Information has been reported in a study. The report includes VAERS reports following PNEUMOVAX 23 or Pneumococcal polysaccharide vaccine (PPSV23) brand unknown after 2002. The report includes reports information from 01-JAN-1990 to 31-JAN-2014. This spontaneous report as received from a other health professional refers to 5 patients. The median age of the patients was 69 years old; range being 23 to 98 years. Between 01-JAN-1990 and 31-DEC-2013 patients were vaccinated with PNEUMOVAX 23. On an unknown date the patients experienced death. The outcome of death was reported as fatal. The cause of death was reported as other infectious. The death of the patients was confirmed with medical records, autopsy reports and/or death certificates. The report has been split into cases according to cause of death. This case is linked to same reporter linked cases 1406USA003857 (respiratory disorder), 1406USA003863 (Unknown), 1406USA003859 (other non infectious disorder), 1406USA003860 (gastrointestinal), 1406USA003861 (Neurological), 1406USA003862 (Undetermined) and 1406USA003351 (Cardiovascular). Additional information has been requested.
Age: 1.45
Sex: M
Vaccine: DTAP, HIBV
Symptoms: Dyskinesia, Pyrexia, Vomiting
Clinical narrative: RN wrote a progress note that the mother called and left a message to the HD that her son had a fever of 103 degrees the day after the vaccination administration on 04/15/14, an that she was alternating Tylenol and ibuprofen, and that the fever was down to 100.7 in the Morning of 04/16/14 and the pt. vomited that morning as well. RN left voicemail for mother explain side effects of vaccinations and when to call/ encouraging mother to notify family physician. 06/09/14 - This RN saw mother at immunization appt. in clinic site. Mother stated, "He got better after he vomited on 04/16/14 and I never took him to the doctor, I did get the message from the nurse, the nurse said he would get better, and he did." "He did have some jerking in his sleep though." This RN explained to the mother that the jerking could possibly have indicated a seizure, and explained and showed the mother the most recent print out of the CDC Recommendations to Contraindications and Precautions to Common Vaccinations, and explained that the mother would have to take the child to be evaluated by her family physician as to the appropriateness of future DTaP doses due to the possibility of the child experiences a possible seizure within three days of receiving a DTaP dose. The mother agreed to this and stated that she would take her child to be evaluated, "I go to the Family Practice," she said.
Age: 54.0
Sex: F
Vaccine: TDAP
Symptoms: Injection site bruising, Injection site induration, Injection site pain, Injection site swelling, Injection site warmth
Clinical narrative: Upper left arm bruised, hardened, and swollen an inch in area shot administerd. Warm to touch and very painful. Lymph nodes under that arm painful and advised to see Dr. and follow-up.
Age: 54.0
Sex: F
Vaccine: TDAP
Symptoms: Lymph node pain
Clinical narrative: Upper left arm bruised, hardened, and swollen an inch in area shot administerd. Warm to touch and very painful. Lymph nodes under that arm painful and advised to see Dr. and follow-up.
Age: 1.01
Sex: M
Vaccine: DTAP
Symptoms: Injection site rash, Pruritus, Rash macular
Clinical narrative: Rash at injection site, spread, w/ splotchy raised red areas at other locations. Seemed itchy.
Age: 1.01
Sex: M
Vaccine: DTAP
Symptoms: Erythema multiforme, Injection site erythema, Injection site rash, Pruritus, Rash macular
Clinical narrative: Onset of red rash at injection site. Spread over 1-2d, also blotchy rash at other sites. Seemed itchy. ER dxed as erythema multiforme. Twin brother w/ similar prodrome, similar rash.
Age: 0.65
Sex: M
Vaccine: PNC13
Symptoms: Decreased appetite, Erythema, Irritability, Lethargy, Pyrexia
Clinical narrative: Fever started around lunch time at 99 went up to 101.9F several times & lasted for 5 days.  Treated with Tylenol. Rash started on 4 & spread to cover entire body with raised rash & bright red hives by day 6. By day 7 (today) started subsiding but not gone. Treated with cool water & aloe. Loss of appetite, cranky, & lethargy started on day one & continues. Probably eats half of what he did a week ago.  Just started eating baby food again on Day 6.
Age: 0.65
Sex: M
Vaccine: PNC13
Symptoms: Rash generalised, Urticaria
Clinical narrative: Fever started around lunch time at 99 went up to 101.9F several times & lasted for 5 days.  Treated with Tylenol. Rash started on 4 & spread to cover entire body with raised rash & bright red hives by day 6. By day 7 (today) started subsiding but not gone. Treated with cool water & aloe. Loss of appetite, cranky, & lethargy started on day one & continues. Probably eats half of what he did a week ago.  Just started eating baby food again on Day 6.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Pruritus
Clinical narrative: Pt received ZOSTAVAX in 2013. She had itching that comes and goes on back "above flank". She may have had shingles before getting ZOSTAVAX in 2013. She is going to see new dr to see if itching is shingles. Pt gave permission for manuf to call for more details.
Sex: U
Vaccine: MMR
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a physician refers to unspecified patients. It was reported the unspecified patients were vaccinated with improperly stored M-M-R II (lot#, dose, strength and frequency were unknown) subcutaneous. NO adverse effects were reported. Follow up information has been received from registered nurse. 61 unspecified patients received the improperly stored M-M-R II, lot # J003785 and expiration date: 28-MAR-2015. She stated that the dates of administration of the M-M-R II for the 61 unspecified patients were as followed: 09-JAN-2014, 13-JAN-2014, 14-JAN-2014, 15-JAN-2014, 17-JAN-2014, 20-JAN-2014, 21-JAN-2014, 22-JAN-2014, 24-JAN-2014, 27-JAN-2014, 28-JAN-2014, 29-JAN-2014, 31-JAN-2014, 03-FEB-2014, 05-FEB-2014, 06-FEB-2014, 10-FEB-2014, 11-FEB-2014, 12-FEB-2014, 13-FEB-2014, 20-FEB-2014, 21-FEB-2014, 24-FEB-2014, 25-FEB-2014, 26-FEB-2014, and 27-FEB-2014. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a Nurse refers to a patient of unknown age. The patient's pertinent medical history was not reported. On 04-JUN-2014 the patient was vaccinated with (Oka/Merck) VARIVAX. Concomitant medications were not reported. On 04-JUN-2014, the patient was inadvertently administered with (Oka/Merck) VARIVAX that was incorrectly stored. No adverse effects were reported. The outcome of administered with (Oka/Merck) VARIVAX that was incorrectly stored and no adverse effects was unknown. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: This spontaneous report as received from a health professional via physician refers to a patient of unknown age and gender. On 22-AUG-2013 the patient was vaccinated intramuscularly with the first 0.5 ml dose of GARDASIL. On 01-MAR-2014 the patient was vaccinated intramuscularly with the second 0.5 ml dose of GARDASIL. On 12-MAY-2014 the patient was vaccinated intramuscularly with the third 0.5 ml dose of GARDASIL dose. No adverse effect was reported. Additional information has been requested.
Sex: U
Vaccine: VARZOS
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report as received form a pharmacist and registered nurse refers to two patients of unknown age (gender not reported). On 28-MAY-2014 the patients were inadvertently vaccinated with a dose of expired ZOSTAVAX (lot # J000429, exp. date 10-APR-2014) subcutaneously (dose and lot# not reported). No adverse effect reported. Additional information has been requested.
Sex: U
Vaccine: RV5
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a Registered nurse refers to a unspecified number of patients of unknown gender and unknown age. It was rerpoted that on an unknown date in 2014, the unspecified number of patients received unspecified doses of ROTATEQ, (dose number, lot/batch number, expiration date, route of administration not reproted) that were improperly stored from 20-MAR-2014 to 07-MAY-2014. Nurse stated that vaccines were exposed to 10.5C for 56.05 hours cumulatively through 07-MAY-2014. It was reported that also M-M-R II GARDASIL, PNEUMOVAX and PEDVAX were improperly stored (event captured in MARRS# 1405USA012894, 1406USA000955, 1406USA000956 and 1406USA000958 respectively). No adverse effects were reported. This is one of several reports from the same reporter. Addtioan information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a physician refers to unspecified patients. It was reported that unspecified patients were vaccinated with improperly stored MMR II (lot#, dose, strength and frequency were unknown) subcutaneous. No adverse effects were reported. Follow up information has been received from registered nurse. 61 unspecified patients received the improperly stored MMR II lot #J003785 and expiration date: 28-MAR-2015. She stated that the dates of administration of MMR II for the 61 unspecified patients were as followed: 09-JAN-2014, 13-JAN-2014, 14-JAN-2014, 15-JAN-2014, 17-JAN-2014, 20-JAN-2014, 21-JAN-2014, 22-JAN-2014, 24-JAN-2014, 27-JAN-2014, 28-JAN-2014, 29-JAN-2014, 31-JAN-2014, 03-FEB-2014, 05-FEB-2014, 06-FEB-2014, 10-FEB-2014, 11-FEB-2014, 12-FEB-2014, 13-FEB-2014, 20-FEB-2014, 21-FEB-2014, 24-FEB-2014, 25-FEB-2014, 26-FEB-2014, and 27-FEB-2014. This is one of several reports received from the same source. Additional information has been requested.
Sex: U
Vaccine: MMR
Symptoms: Incorrect storage of drug, No adverse event
Clinical narrative: This spontaneous report as received from a physician refers to unspecified patients. It was reported that unspecified patients were vaccinated with improperly stored M-M-R II (lot#, dose, strength and frequency were unknown) subcutaneous. No adverse effects were reported. Follow up information has been received from registered nurse. 61 unspecified patients received the improperly stored M-M-R II, lot # J003785 and expiration date: 28-MAR-2015. She stated that the dates of administration of the M-M-R II for the 61 unspecified patients were as followed: 09-JAN-2014, 13-JAN-2014, 14-JAN-2014, 15-JAN-2014, 17-JAN-2014, 20-JAN-2014, 21-JAN-2014, 22-JAN-2014, 24-JAN-2014, 27-JAN-2014, 28-JAN-2014, 29-JAN-2014, 31-JAN-2014, 03-FEB-2014, 05-FEB-2014, 06-FEB-2014, 10-FEB-2014, 11-FEB-2014, 12-FEB-2014, 13-FEB-2014, 20-FEB-2014, 21-FEB-2014, 24-FEB-2014, 25-FEB-2014, 26-FEB-2014, and 27-FEB-2014. This is one of several reports received from the same source. Additional information has been requested.
Age: 50.0
Sex: F
Vaccine: VARZOS
Symptoms: No adverse event, Wrong drug administered
Clinical narrative: This spontaneous report as received from a nurse refers to a 50 year (reported as 50s years) old female patient. On an unknown date the patient was vaccinated with VARIVAX (subcutaneous, dose not reported) and ZOSTAVAX, (subcutaneous, dose not reported). These two doses were separated by at least 4 weeks apart. Pertinent medical history and concomitant medications were not reported. The reporter stated that this was not a mistake and vaccinated the patient as she asked to do so. The outcome of the event was unknown. The reporter also stated that the patient now wants to know if that dose of ZOSTAVAX can be used as second dose for the chicken pox. No adverse effects reported. No further details provided. Additional information has been requested.
Sex: U
Vaccine: HPV4
Symptoms: Drug administered to patient of inappropriate age, No adverse event
Clinical narrative: This spontaneous report as received from a nurse refers to a patient of unknown age and unknown gender. The patient's pertinent medical history was not reported. On 03-JUN-2013 the patient was vaccinated with first dose of GARDASIL (Dose 0.5 milliliter (ml)), intramuscular. Concomitant medications were not reported. On 03-JUN-2014, the patient was vaccinated with second dose of GARDASIL. No adverse effects were reported. The outcome of the patient was vaccinated with first dose of GARDASIL on 03-JUN-2013 and second dose of GARDASIL on 03-JUN-2014 was unknown. Additional information has been requested.
Sex: U
Vaccine: VARCEL
Symptoms: Inappropriate schedule of drug administration, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to a patient of unknown age. On an unknown date the patient was vaccinated with (Oka/Merck) VARIVAX dose 1. On an unknown date the patient experienced patient received a first dose of VARIVAX on an unspecified date and would like to receive the second dose now. The second dose of the vaccine would be administered outside the recommended timeframe. No adverse symptoms reported. The outcome of patient received a first dose of VARIVAX on an unspecified date and would like to receive the second dose now and no adverse symptoms is unknown. Additional information has been requested.
Age: 70.0
Sex: F
Vaccine: VARZOS
Symptoms: Local swelling, Rash pruritic
Clinical narrative: Pt reported severe itching rash and swelling on both arms. Had to call doctor to discuss and take steroid creams and BENADRYL.
Age: 44.0
Sex: F
Vaccine: TDAP
Symptoms: Injected limb mobility decreased, Pain in extremity
Clinical narrative: Pain in (L) arm with decreased ROM < 45 degrees ROM. Ice/heat NAPROSYN 500 mg BID x 10 d SOMA 350 at HS x 5 OV 6/9/14.
Age: 4.0
Sex: F
Vaccine: DTAPIPV, MMRV
Symptoms: Fatigue, Hyperhidrosis, Pallor
Clinical narrative: About 2 mins after receiving vaccines she became pale, sweaty, and c/o being tired. Placed on exam table with legs elevated. She recovered after 2-4 min.
Age: 0.56
Sex: F
Vaccine: DTAP, IPV, PNC13, RV5
Symptoms: Miliaria, Rash
Clinical narrative: Rash underneath armpit and neck, also rash on abd. Child taken to ER. Mother stating she was told it was a heat rash, but she will follow-up with MD.
Age: 4.0
Sex: F
Vaccine: DTAP, HEPA, IPV, MMR, VARCEL
Symptoms: Injection site erythema, Injection site swelling, Pyrexia, Rash
Clinical narrative: Arms red, puffy and swollen. Fever on day 2 - none now. Rash on face -fading - not itching.
Age: 18.0
Sex: F
Vaccine: MNQ
Symptoms: Injection site erythema, Injection site induration, Injection site warmth
Clinical narrative: MCV shot given left arm 5-13-14. 5-14-14 left arm red, warm and hard just below shot site. No fever.
Age: 1.0
Sex: F
Vaccine: HEPA, HIBV, MMR, VARCEL
Symptoms: Rash
Clinical narrative: Rash.
Age: 19.0
Sex: F
Vaccine: VARCEL
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Local reaction
Clinical narrative: Local reation at left arm, injection site. Increase redness, warmth and swelling. Instructed to apply cool compress to area.
Age: 64.0
Sex: F
Vaccine: FLU3
Symptoms: Joint injury, Joint range of motion decreased, Musculoskeletal pain, Nuclear magnetic resonance imaging, X-ray limb
Clinical narrative: Left shoulder injury w/ pain and limited range of motion following flu shot. Pain began approx 6 hours after injection and became worse w/ time. Treatment started with 2 rounds of steroids by mouth, then 3 months later a steroid injection into shoulder joint. Plus 8 weeks of physical therapy. Six weeks later I had 2nd steroid injection pain still persists.
Age: 14.0
Sex: M
Vaccine: HPV4
Symptoms: Injection site erythema, Injection site swelling
Clinical narrative: Redness and swelling 2 inches below shot injection site.
Age: 11.0
Sex: M
Vaccine: HPV4, MNQ, TDAP, HPV4, MNQ, TDAP
Symptoms: Cellulitis, Erythema, Local swelling, Tenderness
Clinical narrative: Swelling, redness and mildly tender on left arm. Cellulitis.
Age: 1.07
Sex: M
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Pyrexia
Clinical narrative: Fever.
Age: 0.52
Sex: F
Vaccine: DTAPIPVHIB, HIBV, PNC13, RV5
Symptoms: Inappropriate schedule of drug administration
Clinical narrative: None.
Age: 1.02
Sex: F
Vaccine: HEPA, MMR, VARCEL
Symptoms: Febrile convulsion
Clinical narrative: Febrile seizure, up to 4 minutes duration 5-31-14. EMS called, patient evaluated there in office later. Only treatment was ibuprofen.
Age: 37.0
Sex: M
Vaccine: TDAP
Symptoms: Abscess, Arthropathy, Cellulitis, Mobility decreased, Musculoskeletal pain
Clinical narrative: Unable to move arm without severe pain in shoulder; waited 7 days with no improvement; went to clinic - diagnosis abscess cellulitis of axillary arm. Theorized serum went to joint.
Age: 37.0
Sex: M
Vaccine: TDAP
Symptoms: X-ray
Clinical narrative: Unable to move arm without severe pain in shoulder; waited 7 days with no improvement; went to clinic - diagnosis abscess cellulitis of axillary arm. Theorized serum went to joint.
Age: 0.51
Sex: F
Vaccine: DTAPIPVHIB, HIBV, PNC13, RV5
Symptoms: Drug administered to patient of inappropriate age
Clinical narrative: None stated.
Age: 7.0
Sex: F
Vaccine: MMR
Symptoms: Abdominal pain upper, Agitation, Erythema, Pallor, Pruritus
Clinical narrative: 2 minutes after receiving vaccine, local area of arm became very red and uncomfortably itchy.  She got agitated, and then had severe stomach pain.  Became pale and very subdued.  Monitored vitals, as still in doctors office, offered water and cookies once she started to feel a little better, after 20 minutes, rash fading and feeling better.  Color returned.  Day later, rash developed and very itchy on proximal arm same side as shot.  Faded relatively soon.  Released from doctors office once she was stable and back to normal.
Age: 7.0
Sex: F
Vaccine: MMR
Symptoms: Rash
Clinical narrative: 2 minutes after receiving vaccine, local area of arm became very red and uncomfortably itchy.  She got agitated, and then had severe stomach pain.  Became pale and very subdued.  Monitored vitals, as still in doctors office, offered water and cookies once she started to feel a little better, after 20 minutes, rash fading and feeling better.  Color returned.  Day later, rash developed and very itchy on proximal arm same side as shot.  Faded relatively soon.  Released from doctors office once she was stable and back to normal.
Age: 45.0
Sex: F
Vaccine: TD
Symptoms: Injection site atrophy, Injection site bruising, Injection site erythema, Injection site reaction, Skin exfoliation
Clinical narrative: Indentation at site of shot started out small and is now the size of a golf ball scaling, red and now bruising.
Age: 37.0
Sex: F
Vaccine: PPV
Symptoms: Injection site erythema, Injection site swelling, Pain, Ultrasound scan normal, White blood cell count increased
Clinical narrative: Redness and swelling on Right upper arm, where Pneumococcal vaccine was given previous day (triceps area, about 24hrs prior).  Complained of significant pain (10/10).
Age: 1.01
Sex: F
Vaccine: HEPA, MMR, PNC13, VARCEL
Symptoms: Allergy to vaccine, Food allergy, Rash generalised, Viraemia
Clinical narrative: Admitted to ER 6/26 after generalized rash faded and bulls eye rash appeared 3 days later.  ER MD diagnosed as viremia.  Primary MD diagnosed as MMR allergy.
Age: 46.0
Sex: F
Vaccine: TDAP
Symptoms: Headache, Impaired work ability, Serum sickness-like reaction
Clinical narrative: I am a doctor and have never had any reactions to any vaccinations.  About 8 hours after a TDAP booster (I also had a TDAP in 2006) I developed a severe headache and serum sickness-like reaction, lasted 48 hours.  I was too sick to work for 2 days, and I never miss work.
Age: 0.17
Sex: M
Vaccine: DTAPHEPBIP, RV5
Symptoms: Abdominal discomfort, Abdominal pain upper, Diarrhoea, Irritability, Lactose intolerance
Clinical narrative: Persistent diarrhea- lasted over 3 weeks. Extreme fussiness due to stomach pain, and developed transient lactose intolerance. On 05/02/2014 started a pro-biotic and eliminated dairy from mother's diet, as baby is breast fed. It took 3 weeks from the start of treatment before dairy could be tolerated again. Dairy is still limited in Mother's diet because it upsets his stomach if there is too much. He never had any problems or reactions to dairy before he received the Rota Teq vaccine.
Age: 35.0
Sex: M
Vaccine: MNQ, TYP, YF
Symptoms: Wrong drug administered
Clinical narrative: Date of Last Typhoid shot 19Mar2014. Gave the Patient another Typhoid Shot on 10Jun2014 instead of the Yellow Fever Vaccine he was supposed to recieve.  Patient was notified of event, and recieved the Yellow Fever vaccination.
Age: 28.0
Sex: F
Vaccine: HEP
Symptoms: Dizziness, Dysstasia, Feeling abnormal, Headache, Mental impairment
Clinical narrative: Very dizzy, vomiting, vision change, stiff neck, headache, brain fog, could't think or talk right, hands shaking, fever, tingling in head  couldn't get out of bed or stand no more than 20 mins this lasted very strong for 5 months.
Age: 28.0
Sex: F
Vaccine: HEP
Symptoms: Mobility decreased, Musculoskeletal stiffness, Paraesthesia, Pyrexia, Speech disorder
Clinical narrative: Very dizzy, vomiting, vision change, stiff neck, headache, brain fog, could't think or talk right, hands shaking, fever, tingling in head  couldn't get out of bed or stand no more than 20 mins this lasted very strong for 5 months.
Age: 28.0
Sex: F
Vaccine: HEP
Symptoms: Tremor, Visual impairment, Vomiting
Clinical narrative: Very dizzy, vomiting, vision change, stiff neck, headache, brain fog, could't think or talk right, hands shaking, fever, tingling in head  couldn't get out of bed or stand no more than 20 mins this lasted very strong for 5 months.
Age: 56.0
Sex: F
Vaccine: VARZOS
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth
Clinical narrative: Pt reported localized swelling, redness, warmth at injection site approx. 3 in x 3 in, no fever, no itching, no other symptoms.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Asthenia, Blood test abnormal, Hyperaesthesia, Influenza like illness, Nerve stimulation test abnormal
Clinical narrative: Flu like symptoms (extreme). Extreme weakness, lack of energy, tingling in extremities, sensitivity to touch.
Age: 71.0
Sex: F
Vaccine: FLU3
Symptoms: Paraesthesia
Clinical narrative: Flu like symptoms (extreme). Extreme weakness, lack of energy, tingling in extremities, sensitivity to touch.
Age: 1.5
Sex: U
Vaccine: MMRV, VARCEL
Symptoms: Incorrect dose administered, No adverse event
Clinical narrative: This spontaneous report as received from a registered nurse refers to a 16 month old patient of an unknown gender. On an unknown date the patient was vaccinated with both (Oka/Merck) VARIVAX, subcutaneous (lot number and expiration date not reported) and (Oka/Merck) PROQUAD (route, lot number and expiration date not reported) in error. No know adverse effects. At the time of the report the outcome of the events was unknown. Additional information has been requested.
Age: 39.0
Sex: F
Vaccine: FLUN4
Symptoms: Asthma, Bedridden, Blood test abnormal, Cough, Dyspnoea
Clinical narrative: Flu like symptoms within 2 hours of sore throat, coughing, fever, aches, laryngitis, full clinical influenza, then secondarily pneumonia.  Bed ridden for 2 weeks, numerous incidents of being bedridden afterwards.
Age: 39.0
Sex: F
Vaccine: FLUN4
Symptoms: Fatigue, Influenza, Influenza like illness, Laryngitis, Oropharyngeal pain
Clinical narrative: Flu like symptoms within 2 hours of sore throat, coughing, fever, aches, laryngitis, full clinical influenza, then secondarily pneumonia.  Bed ridden for 2 weeks, numerous incidents of being bedridden afterwards.
Age: 39.0
Sex: F
Vaccine: FLUN4
Symptoms: Pain, Pneumonia viral, Pulmonary function test abnormal, Pyrexia, Viral test positive
Clinical narrative: Flu like symptoms within 2 hours of sore throat, coughing, fever, aches, laryngitis, full clinical influenza, then secondarily pneumonia.  Bed ridden for 2 weeks, numerous incidents of being bedridden afterwards.
Sex: F
Vaccine: VARZOS
Symptoms: Expired drug administered, No adverse event
Clinical narrative: This spontaneous report as received from a pharmacist refers to a female patient of unknown age. On 31-MAY-2014 the patient was vaccinated with first expired dose of ZOSTAVAX (vial, dose 0.65 ml, subcutaneous, (lot # was not specified), expiry date 08-MAY-2014). No adverse effects were reported. No PQC was involved. Additional information is not expected.
Age: 34.0
Sex: M
Vaccine: TDAP
Symptoms: Vaccination site erythema
Clinical narrative: Extended erythyma on vaccine site, greater than 3 inches.
Age: 59.0
Sex: M
Vaccine: TDAP
Symptoms: Arthralgia, Insomnia, Musculoskeletal pain, Pain, Pain in extremity
Clinical narrative: Constant extreme pain in shoulders and arms as if flesh being torn off the bone.  Moved to hips and knees. Painful to move. Unable to sleep for weeks.
Age: 1.02
Sex: F
Vaccine: MMR
Symptoms: Rash generalised, Urticaria
Clinical narrative: Hives and rash all over after receiving MMR vaccine.